The American Society of Clinical Oncology is taking a stand against unsustainable pricing on cancer drugs. The group has launched an effort to rate cancer drugs not only on their benefits and side effects, but on their prices as well, and they’re recommending oncologist consult its scorecard before deciding on a treatment plan. Read more here. (Source: Tracy Staton, FiercePharma, 3/26/14).
You are here: / / Are You Involved? You Better Be! ASCO Rating Drugs On Price:Value Ratio!